MENTAL HEALTH


has been cut because of the drive to treat and manage patients in their homes and in community as much as possible. This has caused issues with bed management, primarily due to the fact that the services and resources are not available to accommodate patients in community and primary care who require specialist help. This has a huge impact on them as individuals as they are unable to be discharged to community and, as a consequence, hospital beds are full.


I would like to see more emphasis on mental health in pharmacists’ training and more courses and seminars organised by the pharmacy profession in Scotland. The more pharmacists there are in mental health, the better the profi le of mental health pharmacy will be. This would also help us to run pharmacist-led clinics, not only to look after patients’ mental health medication, but to also monitor their physical health so that we can try to stop people with some mental illnesses dying fi fteen to 20 years younger than the general population.


THE VIEW FROM GENERAL PRACTICE PHARMACY


CHRIS JOHNSON, SPECIALIST PRESCRIBING SUPPORT PHARMACIST, PRIMARY CARE, NHS GREATER GLASGOW AND CLYDE PHARMACY AND PRESCRIBING SUPPORT UNIT


When I set out to be a pharmacist, I was interested in clinical pharmacy and that hasn’t changed. Clinical pharmacy is about working with people and most people engage with the health service in primary care, so that’s a good place for me to work. I am interested in the person and how we can best use medicines, where appropriate, to help that person. It doesn’t matter to me whether it is a mental health medicine or a non-mental health medicine, it is a medicine. Our job as pharmacists is to minimise harm and get the best effect for that individual at that point. However, it is important to revisit and review the individual and their medicines after a period to ensure that the medicines are still appropriate and, if not, stop them.


Part of my work has been reviewing long-term benzodiazepine and z-hypnotic use and enabling GPs to feel competent and comfortable reducing benzo-type drugs, which is important not just from a mental


health point of view, but also because of their role in falls and other avoidable drug harms. At the same time, some prescribers may now be using more antipsychotics instead of benzo-type drugs, which have signifi cant cardiometabolic risks. A larger part of my work focuses on supporting the appropriate use of antidepressants. This grew from the antidepressant HEAT target work and provides part of the ongoing framework, as requested by the Scottish Government. A signifi cant part of this work is supporting GPs to review people receiving the same antidepressant long-term (≥2 years); since 2009/10 we have enabled more than 180 practices in NHS Greater Glasgow and Clyde to review over 8000 people, with the work continuing as a prescribing indicator.


There is no health without mental health, therefore a mental health medicines review should be part of a general review. For instance, if I optimise a patient’s COPD medication, it may help reduce their anxiety due to shortness of breath. From my point of view, we as pharmacists need to be leading on the complicated and complex polypharmacy work, which I accept is the inverse of how the new GP contract is worded when it comes to pharmacotherapy services. We don’t want to de-skilled GPs, but we need to work to our strengths, optimising individualised pharmaceutical care and enabling general practices to be more effi cient.


I realise some pharmacists may be apprehensive about working closely with people with mental illnesses because of all the media stereotypes of people with mental illness being ‘nutters’. That’s such a load of rubbish. Everybody at some stage has had emotional distress or some form of challenge of an emotional nature such that, had they had a diagnosis at that point, they may have been classifi ed as having clinical depression or generalised anxiety disorder. As pharmacists, we need to get the medicines right for people who are ill, whatever their illness.


THE VIEW FROM COMMUNITY PHARMACY


NOEL WICKS, MANAGING DIRECTOR, RIGHT MEDICINE PHARMACY


I think it is inevitable that, as people are taking some responsibility for their


‘EVERYBODY AT SOME STAGE HAS HAD EMOTIONAL DISTRESS OR SOME FORM OF CHALLENGE OF AN EMOTIONAL NATURE SUCH THAT, HAD THEY HAD A DIAGNOSIS AT THAT POINT, THEY MAY HAVE BEEN CLASSIFIED AS HAVING CLINICAL DEPRESSION OR GENERALISED ANXIETY DISORDER. AS PHARMACISTS, WE NEED TO GET THE MEDICINES RIGHT FOR PEOPLE WHO ARE ILL, WHATEVER THEIR ILLNESS.’


own health and people are being signposted to community pharmacy as somewhere to get help easily and quickly, more people will come through our doors with mental as well as physical illnesses.


I think the challenge for us is how to build the right vehicle in community pharmacy to be able to help these people ourselves and, in turn, to be sure we signpost them to the right places. When people are signposted to community pharmacy as an alternative to their GP, we have tools we can use associated with that, such as the Minor Ailment Service. So, equally, we need to have the right tools to make sure pharmacists and pharmacy staff meet the expectations of people who bring mental health issues to us.


There are so many factors that can be in play to make someone mentally unwell and, while we have a central role in ensuring their medicines are managed correctly, there are many different other options that also come into play when we consider the person holistically – and we need to know how to help them access these options. If I want someone who has come to the pharmacy to go on to see a doctor, I give the doctor a call there and then and book them an appointment before they leave. I want to be able to make direct referrals in that same way to nonpharmacological therapies, whether it is counselling


or support groups or local patient groups.


Community pharmacists prescribing in mental health is clearly going to be an interesting area in the near future. In the same way as we might talk about a rapid start contraceptive pill, we may potentially need to be able to offer a rapid start mental health intervention for certain conditions. And, if someone is on a medicine, community pharmacy can undertake ongoing monitoring and titration of doses. A doctor may, for example, do the diagnosing and hand over to the pharmacy for the prescribing, then we’d start off on a particular dose, review its effectiveness and adjust it accordingly.


There is huge potential for pharmacists to support people in their communities who have mental health problems. A lot of this is not new. In fact, we’ve always done it. We know at fi rst hand what people suffering from mental ill health want from their pharmacy in terms of advice, a second opinion, a conversation about different therapy options and answers on how long they should be taking a medicine for, or if they should come off it and, if so, how? This sort of support goes on continually in the background. We are already playing a not insignifi cant role. Given the right tools, there is defi nitely scope for us to do more. •


SCOTTISH PHARMACIST - 9


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64